Ā | Adjusted | |
---|---|---|
sHRa(95%C.I.) | p-value | |
Cancer vs. Non-cancer | 2.46 (1.71ā3.52) | <.0001 |
Comorbidities | ||
āMyocardial infarct | 1.98 (0.98ā3.99) | 0.0557 |
ācongestive heart failure | 1.56 (0.98ā2.49) | 0.0632 |
āperipheral vascular | 0.53 (0.17ā1.64) | 0.2717 |
ācerebrovascular disease | 0.83 (0.57ā1.20) | 0.3263 |
ādementia | 0.97 (0.40ā2.34) | 0.9477 |
āchronic lung disease | 1.26 (0.74ā2.17) | 0.3943 |
āconnective tissue disease | 1.23 (0.65ā2.32) | 0.5240 |
āUlcer | 1.31 (0.67ā2.56) | 0.4305 |
āchronic liver disease | 1.43 (0.32ā6.48) | 0.6403 |
āDiabetes | 1.04 (0.67ā1.63) | 0.8608 |
ādiabetes with end organ damage | 1.24 (0.55ā2.79) | 0.5993 |
āHemiplegia | 1.80 (0.52ā6.24) | 0.3566 |
āmoderate or severe kidney disease | 1.84 (0.64ā5.32) | 0.2614 |
āModerate or severe liver disease | ā | Ā |
āAIDS | ā | Ā |
Metastasis | 1.17 (0.68ā2.01) | 0.5754 |
Ā | ā | Ā |